Correlation Between Vincerx Pharma, and SpringWorks Therapeutics

Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma, and SpringWorks Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma, and SpringWorks Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vincerx Pharma, Common and SpringWorks Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma, and SpringWorks Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma, with a short position of SpringWorks Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma, and SpringWorks Therapeutics.

Diversification Opportunities for Vincerx Pharma, and SpringWorks Therapeutics

-0.37

Correlation Coefficient

Vincerx Pharma,  SpringWorks Therapeutics

Very good diversification

The 3 months correlation between Vincerx and SpringWorks is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma, Common and SpringWorks Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SpringWorks Therapeutics and Vincerx Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma, Common are associated (or correlated) with SpringWorks Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SpringWorks Therapeutics has no effect on the direction of Vincerx Pharma, i.e., Vincerx Pharma, and SpringWorks Therapeutics go up and down completely randomly.

Pair Corralation between Vincerx Pharma, and SpringWorks Therapeutics

If you would invest  4,621  in SpringWorks Therapeutics on May 1, 2025 and sell it today you would earn a total of  78.00  from holding SpringWorks Therapeutics or generate 1.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	2.38%
Values	Daily Returns

Vincerx Pharma, Common  vs.  SpringWorks Therapeutics

Vincerx Pharma, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vincerx Pharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Vincerx Pharma, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

SpringWorks Therapeutics

Risk-Adjusted Performance

Solid

Over the last 90 days SpringWorks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, SpringWorks Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Vincerx Pharma, and SpringWorks Therapeutics

The main advantage of trading using opposite Vincerx Pharma, and SpringWorks Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma, position performs unexpectedly, SpringWorks Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SpringWorks Therapeutics will offset losses from the drop in SpringWorks Therapeutics' long position.

The idea behind Vincerx Pharma, Common and SpringWorks Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.